---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294539700.md"
description: "BioAge Labs shares are trading lower amid possible sympathy with Novo Nordisk after its ZEUS phase 3 trial did not translate into a MACE risk reduction."
datetime: "2026-07-31T16:20:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294539700.md)
  - [en](https://longbridge.com/en/news/294539700.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294539700.md)
generator: "portal-rs"
---

# 

BioAge Labs shares are trading lower amid possible sympathy with Novo Nordisk after its ZEUS phase 3 trial did not translate into a MACE risk reduction.

### Related Stocks

- [BIOA.US](https://longbridge.com/en/quote/BIOA.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)

## Related News & Research

- [Novo to outline updated corporate strategy at Capital Markets Day in London](https://longbridge.com/en/news/298878394.md)
- [Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports](https://longbridge.com/en/news/298257409.md)
- [Teamwork Financial Advisors LLC Has $244,000 Stock Position in Novo Nordisk A/S $NVO](https://longbridge.com/en/news/298448421.md)
- [Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture | NVO Stock News](https://longbridge.com/en/news/298879152.md)
- [Novo Nordisk A/S - share repurchase programme | NVO Stock News](https://longbridge.com/en/news/298207087.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**